(Total Views: 393)
Posted On: 12/09/2019 1:54:01 PM
Post# of 72447
Re: NotRichYet2 #61328
$2.5 billion for a phase 1 cancer drug. The difference being that their market cap was already around $1 billion.
A good, small phase 2a oral Kevetrin trial could translate into a billion dollar buyout very quickly.
A good, small phase 2a oral Kevetrin trial could translate into a billion dollar buyout very quickly.
(1)
(1)
